A single center real-world study of Dupilumab in the treatment of moderate to severe atopic dermatitis in elderly patients

Authors

Chaoying Gu (ORCID: https://orcid.org/0000-0002-5467-4671)
Yuemeng Wu (ORCID: https://orcid.org/0000-0002-4119-2921)
Huibin Yin (ORCID: https://orcid.org/0000-0001-9354-4899)
Xu Yao (ORCID: https://orcid.org/0000-0003-3509-4775)
Wei Li (ORCID: https://orcid.org/0000-0002-7245-9772)
Shangshang Wang (ORCID: https://orcid.org/0000-0001-7257-2444)

Publication Details

Journal: Chinese Science Bulletin (Chinese Version)
Published: 2025-10-16
DOI: https://doi.org/10.1360/tb-2024-1336
Citations: 1
Primary Topic: Dermatology and Skin Diseases
Type: article
Field-Weighted Citation Impact: 2.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

A single center real-world study of Dupilumab in the treatment of moderate to severe atopic dermatitis in elderly patients

Chaoying Gu, Yuemeng Wu, Huibin Yin, Xu Yao et al.

Oct 16, 2025

1 citations

Chinese Science Bulletin (Chinese Version)

Dermatology and Skin Diseases

2.00

article

A single center real-world study of Dupilumab in the treatment of moderate to severe atopic dermatitis in elderly patients

Chaoying Gu, Yuemeng Wu, Huibin Yin, Xu Yao, Wei Li, Shangshang Wang

October 16, 2025article en

1 citations

Abstract

No abstract available for this paper.

Chinese Science Bulletin (Chinese Version)Vol. 71(5-6)

Openalex Percentile: Top 11%

Dermatology and Skin Diseases

2.00

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A single center real-world study of Dupilumab in the treatment of moderate to severe atopic dermatitis in elderly patients — Chaoying Gu, Yuemeng Wu, et al. · Chinese Science Bulletin (Chinese Version) (2025) | TGRS Research Map | TGRS